Charles Riv­er Lab­o­ra­to­ries snaps up Cog­nate for a cool $875M, looks to ex­pand cell and gene ther­a­py CD­MO foothold

5 years ago
Deals
Manufacturing

Hous­ton's Avance Bio­sciences an­nounces an­oth­er ex­pan­sion, this time fo­cused on cell-based as­says

5 years ago
Manufacturing

With long-term da­ta in hand, Vivek Ra­maswamy's Der­ma­vant team dash­es to the goal line with top­i­cal pso­ri­a­sis ...

5 years ago
R&D

Covid-19 roundup: South African vari­ant trips up Pfiz­er/BioN­Tech, Mod­er­na vac­cines while EU seeks an­ti-vari­ant ...

5 years ago
Coronavirus

Ed­uar­do Bra­vo re­turns to bring Eu­ro­pean biotech in on the SPAC splurge

5 years ago
Financing

Eli Lil­ly dan­gles $960M for Rigel's RIPK in­hibitor, tak­ing on Sanofi and De­nali in neu­rode­gen­er­a­tion

5 years ago
R&D

VC style re­turns on 'un­sexy' pub­lic health bets? Gates-backed Ad­ju­vant Cap­i­tal gath­ers $300M to mend a 'fail­ure of ...

5 years ago
Financing

A month af­ter mul­ti-bil­lion dol­lar No­var­tis deal, BeiGene fol­lows up with 're­verse' deal

5 years ago
Deals
China

Ad­vent Life Sci­ences launch­es two funds to­tal­ing $215M, and teams with Har­ring­ton Dis­cov­ery In­sti­tute to trans­late ...

5 years ago
Financing

A step be­hind its ma­jor ex­o­some chal­lenger, Evox scores $95M round for fi­nal leg of race to the clin­ic

5 years ago
Financing

The Covid ef­fect has trig­gered some rad­i­cal changes to the top 50 bio­phar­ma list, bring­ing a whole new group of ...

5 years ago
Pharma

Spy­Biotech cash­es in on Serum In­sti­tute deal, net­ting $32.5M round for its 'su­per­glue' VLP vac­cine tech

5 years ago
Financing

Stephen Elledge's Har­vard lab takes $17M to birth Im­muneID, a high-through­put an­ti­body start­up

5 years ago
Financing

Pfiz­er chips in on $26M raise for rheuma­toid arthri­tis col­lab­o­ra­tor; Han­soh li­cens­es an an­ti-fun­gal for a mys­te­ri­ous ...

5 years ago
News Briefing

Janet Wood­cock slams calls for FDA 'fire­wal­l' amid ad­u­canum­ab de­ba­cle, cit­ing need for col­lab­o­ra­tive drug de­vel­op­ment

5 years ago
People
FDA+

Eli Lil­ly adds new board mem­ber Kim­ber­ly John­son, the COO who helped lead Fan­nie Mae out of the US hous­ing cri­sis

5 years ago
People
Pharma

Mov­ing up the lines, As­traZeneca stakes an­oth­er PhI­II win for Lyn­parza as ad­ju­vant breast can­cer ther­a­py

5 years ago
R&D

Glax­o­SmithK­line bets an­oth­er $345M cash on Vir, ex­pand­ing Covid-19 part­ner­ship to flu, RSV and oth­er virus­es

5 years ago
Financing

Gene edit­ing ex­pert Char­lie Al­bright tells us why he hopped from Ed­i­tas to a new role as CSO of an up­start biotech ...

5 years ago
People

Nek­tar, stung by new in­vestor law­suit over IL-2 drug, se­cures $150M for Keytru­da com­bo piv­otal tri­al

5 years ago
Deals

Covid-19 roundup: EC strikes deals with Pfiz­er, Mod­er­na for an­oth­er 350 mil­lion vac­cine dos­es; UK ethics body OKs ...

5 years ago
Coronavirus

Ex­clu­sive: Af­ter four decades, one re­searcher's rad­i­cal HIV cure fi­nal­ly gets its shot

5 years ago
People
Startups

No­var­tis part­ners with the Gates Foun­da­tion on one of the Holy Grails in gene ther­a­py: a sim­ple, in vi­vo ap­proach to ...

5 years ago
Deals

Pi­o­neer­ing re­gen­er­a­tive med sci­en­tist Lau­ra Nikla­son takes her com­pa­ny pub­lic in the lat­est big SPAC deal. And that ...

5 years ago
Financing
First page Previous page 742743744745746747748 Next page Last page
A service from the Financial Times